STRIDES PHARMA GLOBAL (UK) LTD
Get an alert when STRIDES PHARMA GLOBAL (UK) LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2026-08-11 (in 3mo)
Last made up 2025-07-28
Watchouts
None on the register
Cash
£84K
-42.3% vs 2024
Net assets
£13M
-15.8% vs 2024
Employees
2
0% vs 2024
Profit before tax
-£2M
-9,449.7% vs 2024
Name history
Renamed 1 time since incorporation
- STRIDES PHARMA GLOBAL (UK) LTD 2016-11-28 → present
- STRIDES PHARMA (UK) LIMITED 2015-07-29 → 2016-11-28
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2025-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | £10,476 | -£2,374,761 | |
| Profit before tax | £25,353 | -£2,370,436 | |
| Net profit | £25,353 | -£2,370,436 | |
| Cash | £145,565 | £83,964 | |
| Total assets less current liabilities | — | — | |
| Net assets | £15,040,827 | £12,670,391 | |
| Equity | £15,040,827 | £12,670,391 | |
| Average employees | 2 | 2 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Current ratio | 0.04x | 0.04x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- MHA
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on these assessments and having regard to the resources available to the entity, the directors have concluded that there is no material uncertainty and that they can continue to adopt the going concern basis in preparing the annual report and accounts.”
Group structure
- STRIDES PHARMA GLOBAL (UK) LTD · parent
- Strides Pharma UK Ltd 100%
- Beltapharm S.p.A 97.94%
Significant events
- “Subsequent to the year end, the board of directors of Strides Arcolab International Limited (parent company) vide resoluted dated April 16,2025 approved for allotment of shares in the company. Accordingly, 1,375,000 ordinary shares were issued in the next year at a premium of £385,000 for the total consideration of £1,760,000.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KUMAR, Vikesh | Director | 2016-05-05 | Aug 1984 | Indian |
| VISVANATHAN, Rajasekar | Director | 2022-09-30 | Jan 1961 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CHANDRAPPA, Seetharamaiah | Director | 2015-07-29 | 2017-03-21 |
| KANCHAN, Sudhir Krishna | Director | 2015-07-29 | 2018-01-30 |
| PARTHASARATHY, Krishnan Tirucherai | Director | 2018-01-30 | 2022-09-30 |
| PILLAI, Mohana Kumar | Director | 2015-07-29 | 2020-06-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Strides Arcolab International Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 38 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-04-29 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-16 | AA | accounts | Accounts with accounts type full | |
| 2025-08-12 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-04-29 | RESOLUTIONS | resolution | Resolution | |
| 2025-04-22 | SH01 | capital | Capital allotment shares | |
| 2024-12-11 | AA | accounts | Accounts with accounts type full | |
| 2024-07-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-25 | CH01 | officers | Change person director company with change date | |
| 2023-12-20 | AA | accounts | Accounts with accounts type full | |
| 2023-08-01 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-04-04 | SH01 | capital | Capital allotment shares | |
| 2022-11-04 | AA | accounts | Accounts with accounts type small | |
| 2022-10-11 | AP01 | officers | Appoint person director company with name date | |
| 2022-10-04 | TM01 | officers | Termination director company with name termination date | |
| 2022-09-05 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2021-09-30 | AA | accounts | Accounts with accounts type small | |
| 2021-08-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-09-24 | AA | accounts | Accounts with accounts type small | |
| 2020-07-30 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2020-06-16 | TM01 | officers | Termination director company with name termination date | |
| 2019-11-28 | AA | accounts | Accounts with accounts type small |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 1
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
—
Not reported
-
Cash
-42.3%
£145,565 £83,964
-
Net assets
-15.8%
£15,040,827 £12,670,391
-
Employees
0%
2 2
-
Operating profit
-22,768.6%
£10,476 -£2,374,761
-
Profit before tax
-9,449.7%
£25,353 -£2,370,436
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers